LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Adenoviral Gene Therapy Vectors in Clinical Use-Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety.

    Leikas, Aleksi J / Ylä-Herttuala, Seppo / Hartikainen, Juha E K

    International journal of molecular sciences

    2023  Volume 24, Issue 22

    Abstract: Adenoviral vectors are commonly used in clinical gene therapy. Apart from oncolytic adenoviruses, vector replication is highly undesired as it may pose a safety risk for the treated patient. Thus, careful monitoring for the formation of replication- ... ...

    Abstract Adenoviral vectors are commonly used in clinical gene therapy. Apart from oncolytic adenoviruses, vector replication is highly undesired as it may pose a safety risk for the treated patient. Thus, careful monitoring for the formation of replication-competent adenoviruses (RCA) during vector manufacturing is required. To render adenoviruses replication deficient, their genomic E1 region is deleted. However, it has been known for a long time that during their propagation, some viruses will regain their replication capability by recombination in production cells, most commonly HEK293. Recently developed RCA assays have revealed that many clinical batches contain more RCA than previously assumed and allowed by regulatory authorities. The clinical significance of the higher RCA content has yet to be thoroughly evaluated. In this review, we summarize the biology of adenovirus vectors, their manufacturing methods, and the origins of RCA formed during HEK293-based vector production. Lastly, we share our experience using minimally RCA-positive serotype 5 adenoviral vectors based on observations from our clinical cardiovascular gene therapy studies.
    MeSH term(s) Humans ; Adenoviridae/genetics ; HEK293 Cells ; Genetic Vectors/genetics ; Genetic Therapy/adverse effects ; Genetic Therapy/methods ; Virus Replication/genetics
    Language English
    Publishing date 2023-11-20
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms242216519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Intramyocardial adenoviral vascular endothelial growth factor-D

    Leikas, Aleksi J / Hassinen, Iiro / Kivelä, Antti / Hedman, Antti / Mussalo, Hanna / Ylä-Herttuala, Seppo / Hartikainen, Juha E K

    The journal of gene medicine

    2022  Volume 24, Issue 8, Page(s) e3437

    Abstract: Background: The phase I KAT301 trial investigated the use of intramyocardial adenoviral vascular endothelial growth factor-D: Methods: We analyzed non-invasive risk predictors of ventricular arrhythmias from 12-lead electrocardiography (ECG) as well ... ...

    Abstract Background: The phase I KAT301 trial investigated the use of intramyocardial adenoviral vascular endothelial growth factor-D
    Methods: We analyzed non-invasive risk predictors of ventricular arrhythmias from 12-lead electrocardiography (ECG) as well as heart rate variability (HRV) and the incidence of arrhythmias from 24 h ambulatory ECG at baseline and 3 and 12 months after the GT. In addition, we analyzed the incidence of new-onset arrhythmias and pacemaker implantations during 8.2 years (range 6.3-10.4 years) of follow-up.
    Results: We found no significant increase in arrhythmias, including supraventricular and ventricular ectopic beats, atrial fibrillation, non-sustained ventricular tachycardias, and life-threatening tachycardias, nor changes in the non-invasive risk predictors of ventricular arrhythmias in the AdVEGF-D treated patients. Instead, we found a significant improvement in the very low and high-frequency bands of HRV suggestive of improved cardiac autonomic regulation after GT.
    Conclusions: In conclusion, our results suggest that AdVEGF-D GT does not predispose to arrhythmias and might improve HRV metrics.
    MeSH term(s) Adenoviridae/genetics ; Arrhythmias, Cardiac/genetics ; Arrhythmias, Cardiac/therapy ; Genetic Therapy/methods ; Humans ; Vascular Endothelial Growth Factor D/genetics
    Chemical Substances Vascular Endothelial Growth Factor D
    Language English
    Publishing date 2022-07-06
    Publishing country England
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
    ZDB-ID 1458024-x
    ISSN 1521-2254 ; 1099-498X
    ISSN (online) 1521-2254
    ISSN 1099-498X
    DOI 10.1002/jgm.3437
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-D

    Leikas, Aleksi J / Hassinen, Iiro / Hedman, Antti / Kivelä, Antti / Ylä-Herttuala, Seppo / Hartikainen, Juha E K

    Gene therapy

    2021  Volume 29, Issue 5, Page(s) 289–293

    Abstract: In phase I KAT301 trial, intramyocardial adenovirus-mediated vascular endothelial growth factor - ... ...

    Abstract In phase I KAT301 trial, intramyocardial adenovirus-mediated vascular endothelial growth factor -D
    MeSH term(s) Adenoviridae/genetics ; Adenoviridae Infections ; Angina Pectoris/genetics ; Angina Pectoris/therapy ; Canada ; Follow-Up Studies ; Gene Transfer Techniques ; Genetic Therapy/adverse effects ; Genetic Therapy/methods ; Humans ; Treatment Outcome ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor D/genetics
    Chemical Substances Vascular Endothelial Growth Factor A ; Vascular Endothelial Growth Factor D
    Language English
    Publishing date 2021-10-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1191036-7
    ISSN 1476-5462 ; 0969-7128
    ISSN (online) 1476-5462
    ISSN 0969-7128
    DOI 10.1038/s41434-021-00295-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Efficacy and Safety of Clinical-Grade Human Vascular Endothelial Growth Factor-D

    Leikas, Aleksi J / Laham-Karam, Nihay / Agtereek, Eline / Peltonen, Hanna M / Selander, Tuomas / Korpisalo, Petra / Holappa, Lari / Hartikainen, Juha E K / Heikura, Tommi / Ylä-Herttuala, Seppo

    Human gene therapy

    2021  Volume 32, Issue 13-14, Page(s) 761–770

    Abstract: Biological bypass through induced angiogenesis by vascular endothelial growth factor D (VEGF-D) gene therapy (GT) is a new concept for the treatment of cardiac ischemia. Serotype 5 adenoviruses are used in the clinical trials for transferring the VEGF-D ... ...

    Abstract Biological bypass through induced angiogenesis by vascular endothelial growth factor D (VEGF-D) gene therapy (GT) is a new concept for the treatment of cardiac ischemia. Serotype 5 adenoviruses are used in the clinical trials for transferring the VEGF-D cDNA into the ischemic myocardium. However, the presence of replication-competent vectors in the adenovirus products is a widely recognized problem that may pose a potential safety risk to the treated patients. We compared three different VEGF-D GT production lots containing different levels of replication-competent adenoviruses (RCA) tested in 3 × 10
    MeSH term(s) Adenoviridae/genetics ; Adenoviridae/metabolism ; Adenoviruses, Human ; Animals ; Genetic Therapy ; Genetic Vectors/genetics ; Humans ; Neovascularization, Pathologic ; Rabbits ; Tissue Distribution ; Vascular Endothelial Growth Factor D/genetics ; Vascular Endothelial Growth Factor D/metabolism
    Chemical Substances Vascular Endothelial Growth Factor D
    Language English
    Publishing date 2021-03-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1028152-6
    ISSN 1557-7422 ; 1043-0342
    ISSN (online) 1557-7422
    ISSN 1043-0342
    DOI 10.1089/hum.2020.299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top